| Filed | Form | Description | |
|---|---|---|---|
| 8/8/24 | DEFM14A | DEFM14A | → |
| 7/24/24 | PREM14A | PREM14A | → |
| 6/29/23 | DEF 14A | DEF 14A | → |
| 6/15/23 | PRE 14A | PRE 14A | → |
| 3/27/23 | DEFA14A | DEFA14A | → |
| 6/1/22 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 11/13/24 | SC 13G/A | SC 13G/A | → |
| 11/7/24 | SC 13G/A | SC 13G/A | → |
| 9/18/24 | 4 | OWNERSHIP DOCUMENT | → |
| 9/18/24 | 4 | OWNERSHIP DOCUMENT | → |
| 9/18/24 | 4 | OWNERSHIP DOCUMENT | → |
| 9/18/24 | 4 | OWNERSHIP DOCUMENT | → |
| ↓ | |||
Alimera Sciences, Inc. was a biopharmaceutical sales company based in Alpharetta, Georgia that specialized in the commercialization and sales of prescription ophthalmic pharmaceuticals.